Go to Page # Page of 25
loading

Drug therapy in the patient with primary myelofibrosis: The options

 Cristiana Solza
  22nd-Apr-2019
Description: MF patients are very different upon clinical presentation Some may not appear to need treatment for several years. Others are very unwell at diagnosis and need treatment straight away
Views: 2571
Domain: Medical
Category: Therapy
Contributing Organization: iweventos
 ‐ More of their Presentations
weSRCH App on Apple
Contents:
Drug therapy in the patient with primary
myelofibrosis: what are the options?
Cristiana Solza, MD, PhD
Associate Professor, Department of Internal Medicine
Universidade do Estado do Rio de Janeiro

Disclosures
According to the Resolution of the Federal Council of Medicine nº 1595/2000 and Resolution of the
Collegiate Board of ANVISA nº 96/2008, I declare that:
Scientific presentations - ... See more

Recent Presentations

...
22 July, 2019
Tine Peeters
21 July, 2019

FDA's Approach to the Opioids Crisis

FDA is working in a prioritized way in multiple areas to confront opioid overdoses while working to ensure patients receive appropriate pain treatment.

...
20 July, 2019